MusclePharm Transmettre P/E
Quel est le Transmettre P/E de MusclePharm?
Le Transmettre P/E de MusclePharm Corp. est -0.74
Quelle est la définition de Transmettre P/E?
Le ratio prix à terme/bénéfice est le rapport entre le prix des actions d'une société et son bénéfice par action estimé pour les douze prochains mois.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Transmettre P/E des entreprises dans Consumer Staples secteur sur OTC par rapport à MusclePharm
Que fait MusclePharm?
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.
Entreprises avec transmettre p/e similaire à MusclePharm
- Energous Corp a Transmettre P/E de -0.77
- Interpace Biosciences Inc a Transmettre P/E de -0.76
- Milestone Pharmaceuticals Inc a Transmettre P/E de -0.76
- Sonnet BioTherapeutics Inc a Transmettre P/E de -0.75
- Aspen Inc a Transmettre P/E de -0.75
- Aclaris Therapeutics Inc a Transmettre P/E de -0.74
- MusclePharm a Transmettre P/E de -0.74
- Karyopharm Therapeutics Inc a Transmettre P/E de -0.73
- Cellectar Biosciences Inc a Transmettre P/E de -0.73
- Surface Oncology Inc a Transmettre P/E de -0.73
- Mersana Therapeutics Inc a Transmettre P/E de -0.72
- MJardin a Transmettre P/E de -0.71
- FibroGen Inc a Transmettre P/E de -0.70